COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
* The name of the leaders are written in '''bold''':
* The name of the leaders are written in '''bold''':
'''First Draft of the page'''
'''First Draft of the page'''
*[[User:Syed Hassan Abbas Kazmi|Syed Hassan Abbas Kazmi, M.D.]]
*'''[[User:Syed Hassan Abbas Kazmi|Syed Hassan Abbas Kazmi, M.D.]]'''
*[[User:Sabawoon Mirwais|Sabawoon Mirwais, M.B.B.S, M.D.]]  
*'''[[User:Sabawoon Mirwais|Sabawoon Mirwais, M.B.B.S, M.D.]]'''
'''Constant Update of the Page'''
'''Constant Update of the Page'''
*[[User:Aisha Adigun|Aisha Adigun, M.D.]]
*[[User:Aisha Adigun|Aisha Adigun, M.D.]]

Revision as of 21:36, 12 August 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are written in bold:

First Draft of the page

Constant Update of the Page

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members